skip to main content

Amiodarone thyroid monitoring — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardCardiovascular TherapeuticsAmiodarone thyroid monitoringGPhC CRA

A patient taking long-term amiodarone attends for a repeat prescription. They ask which routine tests are needed because they feel well. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Liver, thyroid and pulmonary toxicity monitoring

Amiodarone can cause thyroid, liver, pulmonary and ocular adverse effects. Long-term therapy needs appropriate monitoring even when the patient is asymptomatic. In this scenario, the correct option is liver, thyroid and pulmonary toxicity monitoring. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.

Reference: BNF